an emergency neurosurgery for reposition of the cerebral shunt. Subsequent treatment with imiquimod resulted in complete resolution of sBCC. Given the increased risk for the development of BCCs in CCSs, awareness of neurosurgeons is crucial. Avoidance of setting the catheter of the cerebral shunt within the radiotherapy field is highly recommended, in order to avoid unnecessary future surgeries and subsequent morbidity, as in our case.
Introduction
The development of basal cell carcinoma (BCC) on previously irradiated skin is very common. Childhood cancer survivors (CCSs) are at an increased risk for developing BCC on the sites of irradiation later in their lives [1] .
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Established Facts
• Childhood cancer survivors (CCSs) are at an increased risk for developing basal cell carcinomas (BCCs). 
Novel Insights

Case Report
A 49-year-old female visited our outpatient clinic for evaluation of erythematous patches of the scalp. According to her medical history, at the age of 10 years, the patient was diagnosed with astrocytoma and underwent surgical excision and adjuvant radiotherapy. Eight years later, the tumor relapsed and was treated with a second surgery and a new course of radiotherapy. At the sites of irradiation, she gradually developed cicatricial alopecia. At the age of 45 years, she developed hydrocephalus that demanded a peritoneal cerebral shunt. The catheter of the shunt was set right above the irradiated skin. Four years later, she noticed the appearance of symmetrically distributed, asymptomatic, erythematous patches involving the scarring skin.
The scalp lesions had appeared within the last year, and clinical examination revealed well-demarcated, pinkish plaques with superficial erosions over the previously irradiated skin at both sites of the scalp ( Fig. 1 a) . Dermoscopically, the lesions displayed superficial fine telangiectasia, multiple small erosions, and shiny whitered structureless areas, raising the suspicion of superficial BCC (sBCC), which was histopathologically confirmed.
A daily application of imiquimod 5% for 5 days of the week was initiated. During the fourth week of treatment, the inflammatory local skin reaction was complicated with catheter exposure at the site of treatment. The treatment was terminated, and the patient underwent a surgery for reposition of the cerebral shunt with the catheter of the new valve being set at the back. A new 6-week treatment cycle with imiquimod resulted in complete resolution of the sBCC ( Fig. 1 b) . A dermoscopy-directed skin biopsy confirmed complete response, and the patient was set under close clinical and dermoscopic monitoring.
Discussion
Among CCSs, non-melanoma skin cancer (NMSC) is the most commonly occurring type of second malignancy, accounting for 41% of all subsequent cancers [2] . Studies including CCSs who developed NMSC found that white race, family history of skin cancer, longer follow-up, history of radiation therapy, older age at initial cancer diagnosis, and radiation doses to the skin of more than 1 Gy were associated with an increased risk of BCC [3, 4] .
In another study of 13,123 CCSs participants, 213 were identified with more than 1 NMSC, 97% of which were BCCs. Forty-six percent developed multiple tumors, with 32% having 2-4 NMSCs, 7.8% having 5-9, and 6% having 10 or more lesions. The median age of the participants was 23 years, while the median age at the development of the first NMSC was 31 years (7-46). Regarding tumor location, the head and neck were the most common sites of involvement, followed by the back, chest, extremities, abdomen, and pelvis. The percentage of NMSCs that occurred within the radiotherapy field was 90% [3] .
Increased awareness of neurosurgeons on the high risk of NMSC development in CCSs that underwent radiotherapy is crucial. Avoidance of setting catheters of cerebral shunts within the radiotherapy field is highly recommended in order to facilitate the management of possible NMSC at the site of irradiation in the future and reduce complications and morbidity related to unnecessary surgeries. 
